DNA Blood Test is Promising CFS Diagnostic Approach

Hemispherx Biopharma, Inc., (developer of the drug Ampligen) presented new data from a study involving an investigational blood test for Chronic Fatigue Syndrome (CFS) at the IACFS/ME Conference held September 22-25, in Ottawa.

More @ ProHealth

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s